Corvus Pharmaceuticals
CRVS
#7824
Rank
S$0.32 B
Marketcap
$4.81
Share price
3.98%
Change (1 day)
133.85%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2023 (TTM): -$1.16

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.10. In 2022 the company made an earnings per share (EPS) of -$1.17 an increase over its 2021 EPS that were of -$1.39.

EPS history for Corvus Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.16-1.17%
2022-$1.17-16.04%
2021-$1.39404.76%
2020-$0.28-86.79%
2019-$2.09-9.14%
2018-$2.30-35.66%
2017-$3.57-60.47%
2016-$9.04348.05%
2015-$2.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.86 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA